Exercise of options
(WorldNews Finland)

Exercise of options Released : 24 Sep 2020 07:15 RNS Number : 9411Z Faron Pharmaceuticals Oy 24 September 2020 Faron Pharmaceuticals Oy (`Faron` or the `Company`) Exercise of options Issue of equity Company announcement, 24 September 2020 at 9.15 (EEST) TURKU, FINLAND- Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, announces that it has received notifications from option holders to exercise D options over 15,000 ordinary shares in the Company at an exercise price of EUR 1.09 (approx. GBP 1.00) per share under the Company`s 2015 Option Plan (`New Ordinary Shares`).The terms and conditions of the 2015 Option Plan are available on the...